Resources | NITAG RESOURCE CENTER

2023 ∙ NACI

Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19

2023 ∙ Conseil Supérieur de la Santé (CSS)

Vaccination of persons at risk of meningococcal infection in Belgium

2023 ∙ Haute Autorité de Santé

Vaccination strategy against pneumococcal infections - Place of pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) in adults

2023 ∙ Haute Autorité de Santé

Update of vaccination recommendations and obligations for students and professionals in the health and medico-social sectors and in close contact with young children 2/2

2023 ∙ Haute Autorité de Santé

Update of vaccination recommendations and obligations for students and professionals in the health and medico-social sectors and in close contact with young children 1/2

2023 ∙ STIKO

Recommendations by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2023

2023 ∙ ACIP

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season

2023

Routine vaccination programme against COVID-19 in the Netherlands

2023

Employee vaccination: tick-borne encephalitis in the Netherlands

2023 ∙ NACI, Anne Pham-Huy, Joseline Zafack, Courtney Primeau, Oliver Baclic, Marina Salvadori, Shelley Deeks

A National Advisory Committee on Immunization (NACI) update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure